Cart
sales@molnova.com
Home - Products - MAPK/ERK Signaling - p38 MAPK - SKLB-163

SKLB-163

CAS No. 1255099-06-9

SKLB-163( SKLB 163 | SKLB163 )

Catalog No. M27829 CAS No. 1255099-06-9

SKLB-163 acts by downregulating RhoGDI, activating JNK-1 signaling pathway and caspase-3, and reducing phosphorylated Akt and p44/42 MAPK.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 354 In Stock
5MG 319 In Stock
10MG 472 In Stock
25MG 753 In Stock
50MG 1051 In Stock
100MG 1414 In Stock
200MG Get Quote In Stock
500MG 2762 In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    SKLB-163
  • Note
    Research use only, not for human use.
  • Brief Description
    SKLB-163 acts by downregulating RhoGDI, activating JNK-1 signaling pathway and caspase-3, and reducing phosphorylated Akt and p44/42 MAPK.
  • Description
    SKLB-163 acts by downregulating RhoGDI, activating JNK-1 signaling pathway and caspase-3, and reducing phosphorylated Akt and p44/42 MAPK.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SKLB 163 | SKLB163
  • Pathway
    MAPK/ERK Signaling
  • Target
    p38 MAPK
  • Recptor
    GABAA
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1255099-06-9
  • Formula Weight
    405.92
  • Molecular Formula
    C18H16ClN3O2S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ClCC(=O)Nc1ccc2nc(SCC(=O)NCc3ccccc3)sc2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Divya K Nair, et al. Synthesis of imidazopyridines from the Morita-Baylis-Hillman acetates of nitroalkenes and convenient access to Alpidem and Zolpidem. Org Lett. 2012 Sep 7;14(17):4580-3.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • EO-1606

    EO-1606 is a p38MAP kinase inhibitor with anti-inflammatory activity and may be used in studies of Alzheimer;s disease and dermatitis.

  • Emprumapimod

    Emprumapimod (PF-07265803) is an orally active and specific inhibitor of mitogen-activated protein kinase p38α MAPK, inhibits LPS-induced production of IL-6, and can be used to study dilated cardiomyopathy induced by the LMNA gene.

  • mulberroside B

    Antitussive, antiasthmatic, hypoglycemic, anti - tumor, treatment of gout.

Sign In Join Free